CTHRC1 and familial pancreatic carcinoma: CCK‐8 proliferation assays and Transwell migration assays were employed to examine the effects of STAT3 inhibition on pancreatic cancer cell proliferation and migratory capacity under CTHRC1‐overexpressing CAFs‐CM stimulation.